FDA Approved: ENALAPRIL MALEATE — Supplemental Application (ScieGen Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for enalapril maleate from ScieGen Pharmaceuticals, Inc. (ANDA 075178).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Hypertension
• Left Ventricular Dysfunction
• Myocardial Infarction

Drugs mentioned

• Enalapril maleate (enalapril maleate)

Snippet

SUPPL AP for ENALAPRIL MALEATE (ENALAPRIL MALEATE)